Physician profile
Raj Sinha
NPI 1164445920
$866,030.00
in general payments reported to CMS, 2019-2025
36 companies · $109K in 2025
The $109K reported for 2025 was more than what 97% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $220K · 2020: $140K · 2021: $73K · 2022: $161K · 2023: $106K · 2024: $57K · 2025: $109K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $133K · Royalty Or License: $105K · Food and Beverage: $14K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $13K · Travel and Lodging: $7,277.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $132,751.54 |
| Royalty Or License | $104,607.32 |
| Food and Beverage | $14,228.26 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $12,897.17 |
| Travel and Lodging | $7,277.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Conformis, INC. | $653,294.90 | 2019-2023 | Itotal Identity Cruciate Retaining Knee Replacement System, Identity Imprint Knee Replacement System, Actera Hip Stem |
| Restor3d, INC. | $164,912.17 | 2024-2025 | |
| Maxx Orthopedics, INC. | $34,105.90 | 2019-2023 | |
| Team_makena_llc | $4,882.80 | 2019 | |
| Stryker Corporation | $3,489.09 | 2020-2025 | Mako, Triathlon |
| Encore Medical, Lp | $2,731.85 | 2020-2021 | |
| Avanos Medical | $459.84 | 2019-2023 | On-Q* Pump and Accessories |
| Fidia Pharma USA INC. | $279.63 | 2019-2021 | |
| Sanara Medtech INC. | $175.84 | 2024 | Celleraterx |
| Zimmer Biomet Holdings, INC. | $168.32 | 2019-2022 | |
| Anika Therapeutics, INC. | $160.87 | 2023 | Tactoset |
| Horizon Therapeutics Plc | $155.88 | 2019-2022 | |
| Pylant Medical | $139.25 | 2023-2025 | |
| Ferring Pharmaceuticals INC. | $117.27 | 2019-2022 | |
| Heron Therapeutics, INC. | $101.65 | 2021-2024 | Zynrelef |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Therapeutics, INC. | $84.95 | 2019-2020 | |
| Globus Medical, INC. | $84.66 | 2025 | Actify 3d |
| Pacira Pharmaceuticals Incorporated | $76.15 | 2020-2025 | Iovera, Exparel, Zilretta |
| Amgen INC. | $67.61 | 2021-2022 | |
| Depuy Synthes Sales INC. | $67.24 | 2021-2023 | Na |
| Djo, LLC | $60.77 | 2019-2020 | |
| Innovation Technologies INC | $47.82 | 2020 | |
| Bioventus LLC | $46.91 | 2019-2020 | |
| Uoc USA INC | $41.20 | 2020 | |
| Medacta USA, INC. | $40.35 | 2021-2023 | Gmk Sphere |
| Heraeus Medical, LLC. | $40.19 | 2020-2023 | Palacos |
| Vertex Pharmaceuticals Incorporated | $38.00 | 2025 | |
| Si-Bone, INC. | $23.43 | 2022 | |
| Sanofi-Aventis U.S. LLC | $18.68 | 2021 | |
| Lilly USA, LLC | $17.91 | 2025 | Mounjaro, Zepbound |
| Convatec INC. | $17.82 | 2019 | |
| Exact Sciences Corporation | $17.69 | 2025 | Cologuard Collection Kit |
| Trevena, INC. | $17.30 | 2021 | |
| Think Surgical, INC. | $16.63 | 2023 | |
| Smith+Nephew, INC. | $15.92 | 2025 | Collagenase Santyl |
| Baudax Bio INC. | $13.51 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Raj Sinha listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.